20240018154. NEW INDAZOLE DERIVATIVES simplified abstract (Hoffmann-La Roche Inc.)

From WikiPatents
Jump to navigation Jump to search

NEW INDAZOLE DERIVATIVES

Organization Name

Hoffmann-La Roche Inc.

Inventor(s)

Cosimo Dolente of Allschwil (CH)

Annick Goergler of Colmar (FR)

David Stephen Hewings of Abingdon (GB)

Georg Jaeschke of Basel (CH)

Christa Ulrike Obst-sander of Reinach BL (CH)

Antonio Ricci of Biel-Benken (CH)

NEW INDAZOLE DERIVATIVES - A simplified explanation of the abstract

This abstract first appeared for US patent application 20240018154 titled 'NEW INDAZOLE DERIVATIVES

Simplified Explanation

The invention described in the patent application is a compound of formula (i) or a pharmaceutically acceptable salt thereof. The compound can be used as a medicament.

  • The compound of formula (i) or its salt is the subject of the invention.
  • The compound has potential applications as a medicament.
  • The patent application provides a simplified explanation of the compound and its potential uses.
  • The compound is defined by the variables R and A, which are further described in the description and claims of the patent application.
  • The invention is not oversold and the abstract does not provide a title.

Potential Applications

  • The compound can be used as a medicament in various medical treatments.
  • It may have applications in the treatment of specific diseases or conditions, although these are not specified in the abstract.

Problems Solved

  • The invention addresses the need for new compounds or salts that can be used as medicaments.
  • It potentially solves problems related to the treatment of certain diseases or conditions, although specific problems are not mentioned in the abstract.

Benefits

  • The compound of formula (i) or its salt offers a new option for medicament development.
  • It may provide improved efficacy or reduced side effects compared to existing medications, although this is not explicitly stated in the abstract.


Original Abstract Submitted

the invention relates to a compound of formula (i) or a pharmaceutically acceptable salt thereof, wherein r-rand a are as defined in the description and in the claims. the compound of formula (i) can be used as a medicament.